biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by OysterBuctoucheon Nov 21, 2019 9:26am

119 Views

Post# 30377653

RE:RE:RE:Uptick -question for Digitel

As an fyi i have never made any negative comments re Digitel. Just dont see the value. However based on his daily contribution obsession to stockwatch it sure seems like a fair question to have him answer. Nothing anyone can do about it -and if he is a regular trader of the stock nothing illegal about it. But you would hope that someone as seemingly passionate about Bioasis as Digitel would not be a trader. Fair question for all other Bioasis shareholdeers to know based on pure quantity of postings.

Bullboard Posts

The investment impact of the U.S. 25% tariff on Canadian imports